Senate Finance Committee to review federal policies on drug shortages
Senate Finance Committee Chair Ron Wyden (D-OR) said Wednesday his committee plans to hold a hearing to look more closely at drug shortages, which have been particularly difficult for some common cancer drugs, monoclonal antibodies targeted at RSV, sterile injectables, and new obesity drugs.
The committee will turn to four experts at Tuesday’s hearing to better understand potential policy solutions from a federal perspective.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.